State Street Corporation 13D and 13G filings for Deciphera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-23 09:45 am Sale |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
STATE STREET CORP STT |
2,470,813 3.080% |
-977,211 (-28.34%) |
Filing |
| 2023-02-03 09:54 am Sale |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
STATE STREET CORP STT |
3,448,024 5.100% |
-482,893 (-12.28%) |
Filing |
| 2022-07-11 1:36 pm Sale |
2022-06-30 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
STATE STREET CORP STT |
3,930,917 5.940% |
-2,547,905 (-39.33%) |
Filing |
| 2022-01-10 10:29 am Purchase |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
STATE STREET CORP STT |
6,478,822 11.080% |
6,478,822 (New Position) |
Filing |